161 related articles for article (PubMed ID: 33779695)
1. Elongation factor eEF2 kinase and autophagy jointly promote survival of cancer cells.
Lenchine RV; Rao SR; Wang X; Fang DM; Proud CG
Biochem J; 2021 Apr; 478(8):1547-1569. PubMed ID: 33779695
[TBL] [Abstract][Full Text] [Related]
2. Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy.
Moore CE; Wang X; Xie J; Pickford J; Barron J; Regufe da Mota S; Versele M; Proud CG
Cell Signal; 2016 Apr; 28(4):284-93. PubMed ID: 26795954
[TBL] [Abstract][Full Text] [Related]
3. Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells.
Xie CM; Liu XY; Sham KW; Lai JM; Cheng CH
Autophagy; 2014 Sep; 10(9):1495-508. PubMed ID: 24955726
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic elongation factor 2 (eEF2) kinase/eEF2 plays protective roles against glucose deprivation-induced cell death in H9c2 cardiomyoblasts.
Kameshima S; Okada M; Yamawaki H
Apoptosis; 2019 Apr; 24(3-4):359-368. PubMed ID: 30737648
[TBL] [Abstract][Full Text] [Related]
5. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer.
Fu LL; Xie T; Zhang SY; Liu B
Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target.
Karakas D; Ozpolat B
J Mol Med (Berl); 2020 Jun; 98(6):775-787. PubMed ID: 32377852
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells.
Zhu H; Yang X; Liu J; Zhou L; Zhang C; Xu L; Qin Q; Zhan L; Lu J; Cheng H; Sun X
Cell Stress Chaperones; 2015 Mar; 20(2):217-20. PubMed ID: 25248493
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 Protects the Heart from ER Stress-Induced Injury by Promoting eEF2K/eEF2-Dependent Autophagy.
Pires Da Silva J; Monceaux K; Guilbert A; Gressette M; Piquereau J; Novotova M; Ventura-Clapier R; Garnier A; Lemaire C
Cells; 2020 Feb; 9(2):. PubMed ID: 32059483
[TBL] [Abstract][Full Text] [Related]
10. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis.
Xie J; Shen K; Lenchine RV; Gethings LA; Trim PJ; Snel MF; Zhou Y; Kenney JW; Kamei M; Kochetkova M; Wang X; Proud CG
Int J Cancer; 2018 May; 142(9):1865-1877. PubMed ID: 29235102
[TBL] [Abstract][Full Text] [Related]
11. Regulation and roles of elongation factor 2 kinase.
Proud CG
Biochem Soc Trans; 2015 Jun; 43(3):328-32. PubMed ID: 26009171
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling.
Wang X; Regufe da Mota S; Liu R; Moore CE; Xie J; Lanucara F; Agarwala U; Pyr Dit Ruys S; Vertommen D; Rider MH; Eyers CE; Proud CG
Mol Cell Biol; 2014 Nov; 34(22):4088-103. PubMed ID: 25182533
[TBL] [Abstract][Full Text] [Related]
13. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.
Leprivier G; Remke M; Rotblat B; Dubuc A; Mateo AR; Kool M; Agnihotri S; El-Naggar A; Yu B; Somasekharan SP; Faubert B; Bridon G; Tognon CE; Mathers J; Thomas R; Li A; Barokas A; Kwok B; Bowden M; Smith S; Wu X; Korshunov A; Hielscher T; Northcott PA; Galpin JD; Ahern CA; Wang Y; McCabe MG; Collins VP; Jones RG; Pollak M; Delattre O; Gleave ME; Jan E; Pfister SM; Proud CG; Derry WB; Taylor MD; Sorensen PH
Cell; 2013 May; 153(5):1064-79. PubMed ID: 23706743
[TBL] [Abstract][Full Text] [Related]
14. eEF2K enhances expression of PD-L1 by promoting the translation of its mRNA.
Wu Y; Xie J; Jin X; Lenchine RV; Wang X; Fang DM; Nassar ZD; Butler LM; Li J; Proud CG
Biochem J; 2020 Nov; 477(22):4367-4381. PubMed ID: 33094805
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Elongation Phase of Protein Synthesis Enhances Translation Accuracy and Modulates Lifespan.
Xie J; de Souza Alves V; von der Haar T; O'Keefe L; Lenchine RV; Jensen KB; Liu R; Coldwell MJ; Wang X; Proud CG
Curr Biol; 2019 Mar; 29(5):737-749.e5. PubMed ID: 30773367
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F
EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles.
Kenney JW; Moore CE; Wang X; Proud CG
Adv Biol Regul; 2014 May; 55():15-27. PubMed ID: 24853390
[TBL] [Abstract][Full Text] [Related]
18. Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing.
Bianco C; Thompson L; Mohr I
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22583-22590. PubMed ID: 31636182
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer.
Wang X; Xie J; Proud CG
Cancers (Basel); 2017 Nov; 9(12):. PubMed ID: 29186827
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases.
Beretta S; Gritti L; Verpelli C; Sala C
Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
